AF
JANX icon

Allworth Financial’s Janux Therapeutics JANX Stock Holding History

Allworth Financial’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.3K Buy
930
+249
+37% +$3.61K ﹤0.01% 3463
2026
Q1 		$9.47K Buy
681
+674
+9,629% +$9.24K ﹤0.01% 3550
2025
Q4 		$97 Sell
7
-1
-13% -$24 ﹤0.01% 4786
2025
Q3 		$196 Sell
8
-15
-65% -$365 ﹤0.01% 4605
2025
Q2 		$532 Hold
23
– – ﹤0.01% 4122
2025
Q1 		$738 Hold
23
– – ﹤0.01% 3568
2024
Q4 		$925 Sell
23
-3
-12% -$159 ﹤0.01% 3422
2024
Q3 		$1.18K Hold
26
– – ﹤0.01% 3165
2024
Q2 		$1.16K Hold
26
– – ﹤0.01% 3116
2024
Q1 		$979 Sell
26
-30
-54% -$653 ﹤0.01% 3088
2023
Q4 		$601 Buy
+56
New +$484 ﹤0.01% 3092

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Allworth Financial's JANX Position: Q2 2026 in Review

Allworth Financial increased its Janux Therapeutics (JANX) stake by 37% in Q2 2026, buying an estimated $3.61K and bringing the position to 930 shares worth $14.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3463.

Allworth Financial first reported a position in JANX in Q4 2023 and has held it in 11 quarters since. 198 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

  • Allworth Financial held 930 shares of Janux Therapeutics worth $14.3K as of Q2 2026.
  • Allworth Financial bought 249 Janux Therapeutics shares in Q2 2026, an estimated $3.61K.
  • Janux Therapeutics made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #3463 holding.
  • Allworth Financial first reported a position in Janux Therapeutics in Q4 2023 and has held it in 11 quarters since.
  • 198 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.